Chen Y - Search Results

1

The prognostic value of immunohistochemical subtyping in Chinese patients with de novo diffuse large B-cell lymphoma undergoing CHOP or R-CHOP treatment.

Xia ZG, Xu ZZ, Zhao WL, Zhao SQ, Ding F, Chen Y, Chen QS, Zheng Y, Zhu Q, Hu JP, Shen ZX, Li JM. Xia ZG, et al. Among authors: chen qs, chen y. Ann Hematol. 2010 Feb;89(2):171-7. doi: 10.1007/s00277-009-0799-2. Epub 2009 Aug 11. Ann Hematol. 2010. PMID: 19669764

2

Loss of promoter methylation contributes to the expression of functionally impaired PRDM1β isoform in diffuse large B-cell lymphoma.

Zhang YW, Xie HQ, Chen Y, Jiao B, Shen ZX, Chen SJ, Zhao WL. Zhang YW, et al. Among authors: chen sj, chen y. Int J Hematol. 2010 Oct;92(3):439-44. doi: 10.1007/s12185-010-0689-3. Epub 2010 Sep 22. Int J Hematol. 2010. PMID: 20859709

3

The myelodysplastic syndromes: analysis of prognostic factors and comparison of prognostic systems in 128 Chinese patients from a single institution.

Zhao WL, Xu L, Wu W, Yan H, Tang W, Hu J, Chen Y, Li JM, Zeng XY, Xiong SM, Shen ZX, Chen Z, Wang ZY, Chen SJ. Zhao WL, et al. Among authors: chen z, chen sj, chen y. Hematol J. 2002;3(3):137-44. doi: 10.1038/sj.thj.6200173. Hematol J. 2002. PMID: 12111649

4

Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006.

Wang AH, Wang YY, Yao Y, Xu ZZ, Zhou L, Wang L, Zhang L, Chen Y, Shen ZX, Hu J, Li JM. Wang AH, et al. Among authors: chen y. J Exp Clin Cancer Res. 2010 Mar 3;29(1):20. doi: 10.1186/1756-9966-29-20. J Exp Clin Cancer Res. 2010. PMID: 20199658 Free PMC article.

5

[A phase II multicenter study to investigate R-ICE as a salvage therapy for relapsed diffuse large B-cell lymphoma].

Guo Y, Chen Y, Hong X, Yu L, Ma J, Shi Y, Liu T, Jiang W, Zhu J, Jin J, Zou P, Wu D, Shen Z. Guo Y, et al. Among authors: chen y. Zhonghua Xue Ye Xue Za Zhi. 2014 Apr;35(4):314-7. doi: 10.3760/cma.j.issn.0253-2727.2014.04.014. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24759019 Clinical Trial. Chinese.

6

[Comparative analysis of decitabine combined with DAG regimen and other regimens in treatment of refractory/relapsed acute myeloid leukemia].

Hao J, Wang L, Wang Y, Liu Z, Gu X, Liu J, Li L, Duan Y, Chen Y, Zhao W, Shen Z. Hao J, et al. Among authors: chen y. Zhonghua Xue Ye Xue Za Zhi. 2014 Jun;35(6):481-5. doi: 10.3760/cma.j.issn.0253-2727.2014.06.001. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24985167 Chinese.

7

Low CLL-1 Expression Is a Novel Adverse Predictor in 123 Patients with De Novo CD34⁺ Acute Myeloid Leukemia.

Wang YY, Chen WL, Weng XQ, Sheng Y, Wu J, Hao J, Liu ZY, Zhu YM, Chen B, Xiong SM, Chen Y, Chen QS, Sun HP, Li JM, Wang J. Wang YY, et al. Among authors: chen wl, chen qs, chen b, chen y. Stem Cells Dev. 2017 Oct 15;26(20):1460-1467. doi: 10.1089/scd.2016.0310. Epub 2017 Sep 21. Stem Cells Dev. 2017. PMID: 28810819 Free PMC article.

8

Optimization of idarubicin and cytarabine induction regimen with homoharringtonine for newly diagnosed acute myeloid leukemia patients based on the peripheral blast clearance rate: A single-arm, phase 2 trial (RJ-AML 2014).

Zhang Y, Li X, Weng X, Shen Y, Chen Y, Zheng Y, Zhao H, You J, Mao Y, Wang L, Wu M, Sheng Y, Wu J, Hu J, Chen Q, Li J. Zhang Y, et al. Among authors: chen q, chen y. Am J Hematol. 2022 Jan 1;97(1):43-51. doi: 10.1002/ajh.26386. Epub 2021 Nov 1. Am J Hematol. 2022. PMID: 34687467 Free article. Clinical Trial.

9

Novel STAT5B-RARA fusion transcript in acute promyelocytic leukemia: identification and treatment response.

Wang YY, Hao J, Liu ZY, Weng XQ, Sheng Y, Jiang CL, Zhu YM, Chen B, Xiong SM, Li JM, Chen QS, Chen HY, Qiao C, Chen Y. Wang YY, et al. Among authors: chen hy, chen qs, chen b, chen y. Leuk Lymphoma. 2015;56(9):2731-4. doi: 10.3109/10428194.2015.1007454. Epub 2015 Feb 11. Leuk Lymphoma. 2015. PMID: 25629986 No abstract available.

10

Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large B-Cell Lymphoma.

Chen GL, Li D, Cao S, Jiang S, Zhang Q, Jin J, Xia Z, Liu Y, Liu X, Zhu Y, Chen Y, Gu L, Hong X, Cao J, Tao R, Lv F. Chen GL, et al. Among authors: chen y. Mediterr J Hematol Infect Dis. 2022 Sep 1;14(1):e2022066. doi: 10.4084/MJHID.2022.066. eCollection 2022. Mediterr J Hematol Infect Dis. 2022. PMID: 36119461 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176,594 results

Search Page

Filters